why choose us

Clinical Trials Search

Showing 7,150 of 132,085 result(s)
Nourishing the Community Through Culinary Medicine- Acres Homes

Status: Completed

Condition: Diabetes

Interventions: The virtual curriculum will include five 90-minute sessions (to be held weekly or bi-weekly).
Participants will also be expected to shop for groc

Date: 2023-10-17

Phase II Clinical Trial of Interleukin-2 in AD

Status: Completed

Condition: Alzheimer Disease

Interventions: Low dose Interleukin-2 (Aldesleukin) administration to expand Regulatory T cells

Date: 2023-10-17

CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study

Status: NOT_YET_RECRUITING

Condition: Cardiac Amyloidosis

Interventions: Intervention group will have baseline 6-minute walk test and cardiopulmonary exercise test (CPET) testing followed by supervised cardiac rehabilitatio

Date: 2023-10-17

Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals

Status: Completed

Condition: Muscle Spasticity

Interventions: Safety and tolerability of oral MTR-601, a highly selective fast twitch myosin 2 ATPase inhibitor in normal healthy volunteers

Date: 2023-10-17

Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia

Status: Completed

Condition: Spasmodic Dysphonia

Interventions: Vibro-tactile stimulation is a non-invasive treatment option.
As stimulators, we will apply a pair of light-weight encapsulated cylindrical vibra

Date: 2023-10-16

Multi-center Trial to Improve Nocturia and Sleep in Older Adults

Status: Completed

Condition: Nocturia

Interventions: Integrated Behavioral Therapy is a behavioral program that includes education, lifestyle habits management, cognitive, relaxation, and behavioral cond

Date: 2023-10-16

Spesolimab in Pyoderma Gangrenosum

Status: Completed

Condition: Pyoderma Gangrenosum

Interventions: 900 mg of spesolimab intravenously (IV) administered at Weeks 0, 3, 6, 9, 12 and 15.

Date: 2023-10-16

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

Status: NOT_YET_RECRUITING

Condition: Breast Cancer

Interventions: 1 ounce of Tart Cherry Concentrate (King Orchard) mixed with 8 ounces of water daily for 12 weeks

Date: 2023-10-16

Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA

Status: NOT_YET_RECRUITING

Condition: OSA

Interventions: Administered for 3 nights, half-dose (1 pill) on the first night followed by full dose (2x250mg pills) for 2 nights

Date: 2023-10-16

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)

Status: NOT_YET_RECRUITING

Condition: Breast Cancer

Interventions: Daily oral dosages of ARV-471 continuously, dose escalation;de-escalation in Phase 1b until RP2D determined, cycles lasting 28 days

Date: 2023-10-16